Samaritan's Alzheimer's Drug Candidate Caprospinol Shows Favorable Results in Acute Toxicity Study
August 29, 2006 10:52 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 29, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) a developer of innovative drugs, announced today, its Alzheimer's research compound Caprospinol (SP-233) demonstrated...
Samaritan Strengthens Business Development Capability
August 23, 2006 11:14 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 23, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce it is strengthening its business development capability with...
Samaritan Pharmaceuticals Inc. Purchases Back Canadian Rights for HIV Drug from Quest PharmaTech
August 08, 2006 10:34 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 8, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce it has purchased back the Canadian licensing rights related to...
Samaritan Plans to Acquire Metastatin Pharmaceuticals to Buy Rights to Novel Cancer Drug
July 27, 2006 10:06 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, July 27, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that Samaritan has signed a letter of intent ("LOI") whereby...
Samaritan Reports Its Alzheimer's Drug Caprospinol Cleans the Brain of Plaque in Preclinical Animal Study
July 11, 2006 09:51 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, July 11, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, its Alzheimer's drug SP-233 (Caprospinol), not only stops amyloid...
Samaritan Builds Up Patent Portfolio: Samaritan Announces U.S. Patent Issued for Peripheral-Type Benzodiazepine Receptor Associated Proteins
June 26, 2006 09:37 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, June 26, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it is continuing to expand its broad worldwide patent portfolio in...
Samaritan Receives a Notice of Claim Allowance in its European Patent for New Type of Plaque Clearing Cardiovascular Drug SP-1000
June 20, 2006 10:52 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, June 20, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, it has received a notice of allowance of claims for European patent...